Segment Reporting (Tables)

3 Months Ended

Mar. 31, 2026

Segment Reporting [Abstract]

Schedule of Operating Financial Results of Reportable Segment

The following table provides the operating financial results of the Company’s single reportable segment. It includes the significant expense categories regularly provided to the Company’s "chief operating decision maker", its Chief Executive Officer, computed under GAAP and reconciled to the Company’s total “net loss” as presented in the Condensed Statements of Operations and Comprehensive Loss:


		Three Months Ended March 31,
(in thousands)		2026				2025
Revenue		$	16,116			$	10,189

Less:
Cost of sales			3,691				2,553
Selling expenses			7,885				5,014
Marketing expenses			1,490				932
Product and software development costs			3,076				1,480
Clinical, medical, and regulatory expenses			1,347				1,021
Other segment expenses*			7,903				4,908
Interest expense			311				357
Interest income			(891	)			(380	)
Change in fair value of warrant liabilities			—				33
Net loss		$	(8,696	)		$	(5,729	)

* Other segment expenses primarily include corporate, compliance, and research and development support expenses.